References
-
1
Weinstein W M.
The prevention and treatment of dysplasia in gastroesophageal reflux disease: the results and the challenges ahead.
J Gastroenterol Hepatol.
2002;
17 (Suppl.)
S113-S124
-
2
Walker S J, Selvasekar C R, Birbeck N.
Mucosal ablation in Barrett's esophagus.
Dis Esophagus.
2002;
15
22-29
-
3
Kahaleh M, Van Laethem J L, Nagy N. et al .
Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Endoscopy.
2002;
34
950-955
-
4
Ell C, May A, Gossner L. et al .
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.
Gastroenterology.
2000;
118
670-677
-
5
Overholt B F.
Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.
Gastrointest Endosc.
1999;
49
1-7
-
6
Sampliner R E.
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.
Am J Gastroenterol.
2002;
97
1888-1895
-
7
Devesa S S, Blot W J, Fraumeni J F Jr.
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.
Cancer.
1998;
83
2049-2053
-
8
Cameron A J.
Epidemiology of Barrett's esophagus and adenocarcinoma.
Dis Esophagus.
2002;
15
106-108
-
9
Gerson L B, Shetler K, Triadafilopoulos G.
Prevalence of Barrett's esophagus in asymptomatic individuals.
Gastroenterology.
2002;
123
461-467
-
10
Incarbone R, Bonavina L, Szachnowicz S. et al .
Rising incidence of esophageal adenocarcinoma in Western countries: is it possible to identify a population at risk?.
Dis Esophagus.
2000;
13
275-278
-
11
Dulai G S, Guha S, Kahn K L. et al .
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review.
Gastroenterology.
2002;
122
26-33
W. M. Weinstein, M.D.
Dept. of Medicine, Division of Digestive Diseases
UCLA Center for Health Sciences 44-138 · Box 951684 · Los Angeles · CA 90095-1684 · USA
Fax: + 1-310-825-1700
Email: wweinste@ucla.edu
